Cogna Educação S.A (COGN3)
B3 Stock Exchange · Brazil · prices in BRL · close of 23 Oct 2026
Key indicators
| Last close | BRL 3.100 |
|---|---|
| 52-week range | 1.990 – 4.750 |
| Return, 1 month / 3 months | +34.8% / +46.9% |
| Return, 1 year / 3 years | +4.6% / +47.2% |
| Trend | Uptrend |
| RSI (14) | 70 |
| Volatility (1 year) | 48.1% |
| Worst drawdown (1 year) | -55.6% |
| Average daily value traded | 94.75M BRL |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cogna Educação is a Brazilian education company that provides private higher education and distance learning to students across Brazil. It runs universities, colleges and online course programmes through brands such as Kroton, Estácio and Unopar, offering undergraduate and postgraduate degrees as well as vocational and continuing education. The company is based in Brazil and serves learners who study both on campus and remotely, with a focus on accessible professional qualifications for working adults and younger students.
The shares are listed on the B3 Stock Exchange in Brazil under the code COGN3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cogna Educação S.A (COGN3) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 3.100 on 23 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 893 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.6% and over the last three months it rose 46.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 10.4% | ||
| From 52-week high | -32.5% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 46.9% | ||
| 6-month return | 5.6% | ||
| 12-month return, skipping the last month | -22.4% | ||
| Stability (higher is calmer) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.6% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 94.75M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 23 · Weak | Dividend is small or irregular. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +7.3% |
|---|---|
| 1 month | +34.8% |
| 3 months | +46.9% |
| 6 months | +5.6% |
| 1 year | +4.6% |
| 3 years | +47.2% |
| 5 years | +39.9% |
Signals
| 50-day / 200-day average | 2.386 / 2.808 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.150 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Apr 2026 | BRL 0.0143 |
| 23 Dec 2025 | BRL 0.1262 |
| 28 Apr 2025 | BRL 0.0734 |
| 19 Nov 2019 | BRL 0.0052 |
| 20 Aug 2019 | BRL 0.0371 |
| 21 May 2019 | BRL 0.0611 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.